跳至主要内容
临床试验/NCT00858832
NCT00858832已完成不适用

Reduction of Endometritis After Cesarean Section With the Routine Use of Methergine

University of South Florida1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2008年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
44
试验地点
1
主要终点
Endometritis Incidence

研究概览

简要总结

Endomyometritis is an "infection in the uterus". It can occur in up to 1 out of 5 women having unplanned cesarean deliveries. Antibiotics are routinely given at the time of Cesarean delivery, but the infection in the uterus can still occur. When endomyometritis occurs it can prolong the woman's stay in the hospital after birth, slow down her recovery time at home, and increase medical costs. Methergine is a medication that is routinely used to stop uterine hemorrhage (excessive bleeding from the uterus) that sometimes happens after delivery. Methergine works by contracting (tightening) the uterus. These contractions also help the uterus to expel or remove parts of the placenta that increase the chance of developing a uterine infection.

This research study is being done to learn if routine use of Methergine can lower the chances of developing a uterine infection after cesarean delivery. Half of the women in this study will receive Methergine for a few days during their hospitalization after cesarean delivery. The other half of the women will not routinely receive Methergine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Female singleton gravidas
  • Patients receiving non-elective cesarean deliveries after trial of labor
  • No evidence of chorioamnionitis

排除标准

  • Diagnosis of chorioamnionitis
  • Elective cesarean section
  • Unable to provide informed consent
  • Immunocompromised patients and those on antiretroviral drugs
  • Patients with known infection
  • Hypertension (blood pressure greater than 140/90 x 2, six hours apart), including those with a past history, gestational or Preeclampsia.
  • Allergic to ergot alkaloids. This would include people allergic to migraine medicine.

研究组 & 干预措施

Methergine

Experimental

Methergine group received Methergine 0.2mg po every 6 hours for two days, plus routine postpartum care.

干预措施: Methergine (Drug)

结局指标

主要结局

Endometritis Incidence

时间窗: One year

Number of participants who developed endometritis

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Reduction of Endometritis After Cesarean Section... | 临床试验